Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by TedSchulz


V.SPN

RE:Absolutely…

I for one was not expecting this type of acquisition for Snipp, however if...

January 11, 2022

V.SPN

RE:RE:SNIPP: Trend setter

Agree with you there, much rather see low volume and slow but steady growth...

January 5, 2022

V.SPN

RE:U.S.

I completely agree with you that Snipp's sole focus should be the US...

January 3, 2022

C.QNTM

Problems in the past ?

Would investing be a good idea? Apparently the problems are in the past, I...

November 12, 2021

C.QNTM

indicators in green

That the indicators are in green can seem good to us, however it is more...

November 8, 2021

C.QNTM

fsd

The last few weeks have been discouraging, despite the different actions to...

November 5, 2021

C.QNTM

FSD

With the acquisition of HUGE, research on the compound Lucid -COVAR is...

November 2, 2021

C.QNTM

Lucid -COVAR

A psychedelic revolution comes to psychiatry and FSD Pharma leads the way...

October 29, 2021

C.QNTM

FSD Pharma to the top

I am optimistic and hope to see growth as a result of the acquisition of...

October 27, 2021

C.QNTM

FSD has an agreement with Covar Pharmaceuticals Inc

FSD has an agreement with Covar Pharmaceuticals Inc. to begin the research of...

October 20, 2021

C.QNTM

FSD will probably improve

If there is a backlog, the company's results are probably improving.

October 12, 2021

C.QNTM

Investors should keep an eye on FSD Pharma

In my opinion, investors should keep an eye on the pharmaceutical market...

October 11, 2021